Morphologic findings in saphenous veins used as coronary arterial bypass conduits for longer than 1 year: Necropsy analysis of 53 patients, 123 saphenous veins, and 1865 five-millimeter segments of veins
References (23)
- et al.
Atherosclerosis in aortocoronary vein grafts
Lancet
(1974) - et al.
Changes in saphenous veins used as aortocoronary bypass grafts
Am Heart J
(1977) - et al.
Pathologic findings in the aortocoronary vein grafts. A scanning electron microscope study
Atherosclerosis
(1978) - et al.
Morphologic changes in long-term saphenous vein bypass grafts
Chest
(1985) - et al.
Thrombosed, ruptured atheromatous plaques in saphenous vein coronary artery bypass grafts. Ten years experience
Am Heart J
(1987) - et al.
Atherosclerostic aneurysms of aortocoronary vein grafts
Am J Cardiol
(1988) - et al.
Aneurysm of saphenous vein bypass graft to coronary artery
J Thorac Cardiovasc Surg
(1975) - et al.
Saphenous vein aneurysms after aortocoronary bypass grafting. Post-operative interval and hyperlipidemia as determining factors
Am Heart J
(1987) Qualitative and quantitative comparison of amounts of narrowing by atherosclerotic plaques in the major epicardial coronary arteries at necropsy in sudden coronary death, transmural acute myocardial infarction, transmural healed myocardial infarction and unstable angina pectoris
Am J Cardiol
(1989)- et al.
Mode of death, frequency of healed and acute myocardial infarction, number of major epicardial coronary arteries severely narrowed by atherosclerotic plaque, and heart weight in fatal atherosclerotic coronary artery disease: analysis of 889 patients studied at necropsy
J Am Coll Cardiol
(1990)
Lipid-lowering therapy after an atherosclerotic event
Am J Cardiol
Cited by (127)
Autologous endothelialized vein allografts in coronary artery bypass surgery – Long term results
2019, BiomaterialsCitation Excerpt :Currently this is of course only a theory and we cannot provide any hard data supporting this idea. Remodeling of coronary vein grafts in response to their new “arterial position” has been an important topic in coronary revascularization for several decades [38]. The condition sometimes termed “vein graft disease” is thought to be caused by the arterial pressure, the pulsatile flow and subsequent mechanical stretch and shear stress which are unnatural for veins [39].
Quantitative Extent of Atherosclerotic Plaque in the Major Epicardial Coronary Arteries in Patients with Fatal Coronary Heart Disease, in Coronary Endarterectomy Specimens, in Aorta-Coronary Saphenous Venous Conduits, and Means to Prevent the Plaques: A Review after Studying the Coronary Arteries for 50 Years
2018, American Journal of CardiologyPX-18 Protects Human Saphenous Vein Endothelial Cells under Arterial Blood Pressure
2017, Annals of Vascular SurgeryIntraoperative Vein Graft Preservation: What Is the Solution?
2016, Annals of Thoracic SurgeryCitation Excerpt :In addition to endothelial cell loss, transient ischemia followed by reperfusion during vein harvesting and grafting reduces endothelial production of antiproliferative mediators, such as prostacyclin and nitric oxide (NO) [31]. Necropsy studies have identified extensive atherosclerotic lesions in SVGs as early as 1 year after coronary bypass operation [36]. Correspondingly, atherosclerosis is the main cause of VGF beyond the first year of graft implantation [37].
Management of Complications During Saphenous Vein Graft Interventions
2013, Interventional Cardiology ClinicsOptimal Stenting in Saphenous Vein Graft Intervention
2013, Interventional Cardiology Clinics
- 1
From the Pathology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health
- *
Present address: Section of Cardiology, Department of Medicine, University Hospital, Boston University Medical Center, Boston, Mass.